AVEDRO, INC.

Avedro, Inc. specializes in the design, development, and manufacturing of precision medical implants and pharmaceutical delivery systems, with deep expertise in ophthalmic and implantable therapeutics. The company’s core capabilities center on the fabrication of drug-eluting implants, particularly those delivering travoprost and other ophthalmic agents via sustained-release technology, alongside surgical instruments and medical devices engineered for minimally invasive procedures. Their technical proficiency spans sterile manufacturing, controlled-release pharmacokinetics, and biocompatible material integration, ensuring compliance with stringent FDA and GMP standards. Avedro differentiates itself through its focus on precision-dose implantables, enabling long-term intraocular pressure management and targeted drug delivery with reduced systemic exposure. The Department of Veterans Affairs is the contractor’s primary federal partner, consistently awarding contracts for ophthalmic implants and pharmaceutical formulations used in veteran eye care programs. These engagements reflect a sustained, mission-aligned relationship focused on delivering high-value, long-duration therapeutic solutions for chronic conditions such as glaucoma, with an emphasis on reducing clinical burden and improving adherence in veteran populations. Avedro’s industry focus lies within pharmaceutical preparation manufacturing and surgical instrument production, specifically in the niche of implantable drug delivery systems. The company occupies a specialized position in the ophthalmic therapeutics market, bridging advanced pharmaceutical science with medical device engineering to create integrated solutions that combine drug formulation with mechanical implant design. Their work supports the growing demand for next-generation intraocular therapies that enhance patient outcomes through sustained, localized treatment. Avedro, Inc. is a small business entity headquartered in Waltham, Massachusetts, with no federal certifications on record. Its geographic and operational footprint is centered in the Boston biotech corridor, positioning it to leverage regional life sciences infrastructure and talent. The company serves the federal healthcare market through targeted, high-precision manufacturing capabilities tailored to the needs of specialized clinical applications.